John Simboli

#strategy #strategiccommunication #branding #corporatecommunications #storytelling #messaging #creative #writer #filmmaker #photographer

[John Simboli @WsgJohn]

Please save the date for the opening reception of my new #photography and #video exhibit on the evening of October 13 at Five Points Gallery Annex, 33 Main St., Torrington, CT @5pointsgallery

#art, #artist, #FineArt, #FineArtPhotography, #fineartvideo, #filmmaking

[Bleep @bleep]

Pre-Order Now:
Born Under A Rhyming Planet - Diagonals
DDS

https://t.co/5CQbfLmGwJ

+ Violet vinyl
+ Mastered by Rashad Becker
+ Limited to 500

[John Simboli @WsgJohn]

New BioBoss podcast https://t.co/S66qfcqZnp Kevin Lee, #CEO @Bicycle_tx with #bioboss host @WSGJohn. #leadership in #biopharma
#biotech,#biopharma,#openscience,#innovation,#BioBoss,#therapeutics,#cancer,#immuno-oncogy,#peptide,#BicyclicPeptides,#scaffolds,#drugdevelopment,#BTC

[Orexo @OrexoABpubl]

Orexo´s novel and innovative drug delivery platform amorphOX will serve as the backbone in the development of our future pharmaceuticals. The applicability is wide as it can be used with different:

1️⃣APIs
2️⃣Dosage forms
3️⃣Administration routes

#orexo #innovation

[Castle Biosciences @CastleBio]

Join us next week as Derek Maetzold, president and CEO, and Frank Stokes, CFO, present a company overview at the 21st Annual Needham Virtual Healthcare Conference. Tuesday, April 12 at 3:00 p.m. ET. Register for the live audio webcast: https://t.co/Mh9R8mviB9

[Spero Therapeutics @Spero_Tx]

#NEWS: Today, we announced the publication of results from a Phase 3 #clinicaltrial evaluating our investigational oral carbapenem #antibiotic in @NEJM. Learn more about the paper: https://t.co/i1R1oMrPpf

[AnimaBiotech @AnimaBiotech]

Anima’s high scale phenotypic screening is running 24/7 in our automated #biology lab🔬generates millions of #mRNA translation images. The system identifies the drugs MOA by #AI analysis. We established 18 pipeline programs and big pharma partnerships🤝 https://t.co/IBIdIni2hp

[Orexo @OrexoABpubl]

GET TO KNOW #OREXO – the 2021 Annual Report is out. It gives a deeper knowledge about the company, our business landscape & financial development. It also includes the Sustainability Report, which outlines major steps taken to contribute to a more sustainable society #ESEF

[John Simboli @WsgJohn]

#BioBoss #podcast https://t.co/lnV1xhx7Cm Reenie McCarthy, #CEO @StealthBT. @reeniemccarthy speaks with BioBoss host John Simboli about #leadership in #biopharma #AMD #rarediseases #MitochondrialDisease #mitochondria $MITO #GA #cardiomyopathy #BarthSyndrome #LHON #Duchenne #DMD

[John Simboli @WsgJohn]

New BioBoss podcast https://t.co/2fM4XFF5XN Bob Cobuzzi, CEO,
Diffusion Pharmaceuticals
#CEO,#biotech,#biopharma,#openscience,#innovation,#therapeutics,#hypoxia,#VA,#UVA,#TSC,#carotenoid,#diffusion,#plasma,#oxyen,#oxygenation,#oxygendiffusion,#DFFN,#leadership,@BioBossPodcast

[John Simboli @WsgJohn]

I enjoyed my #BioBoss podcast conversation with Panna Sharma, #CEO of #LanternPharma, https://t.co/ndXJ5qKDiK
and his perspective on #leadership in #biopharma and the intersection of #AI, #genomics and #machinelearning.

[DetailJunkie 🏴‍☠️🌻🇺🇦 🇵🇱 @DetailJunkie]

@RoivantDiscover is using quantum physics-based molecular dynamics simulation to rationally design small molecule drugs & AlphaFold2 is a step forward in the computational understanding of protein biology. CTO Huafeng Xu’s blog post regarding their research is super interesting!

[Barth Syndrome @BarthSyndrome]

Meet Abe, 1 of just 130 children and young adults in the U.S. living with #BarthSyndrome. Share his family’s video highlighting their experience living with a #raredisease. Help raise their voices to those who determine access to treatment options @US_FDA https://t.co/s8WuPXze3E

[John Simboli @WsgJohn]

Latest #BioBoss #podcast, Lantern Pharma CEO Panna Sharma, https://t.co/ndXJ5qt2rc
Hear my conversation with Panna about #leadership in #biopharma and how Lantern Pharma is working at the intersection of artificial intelligence, genomics and machine learning

[New Day Bio Consulting @NewDayBio]

News: @US_FDA clears clinical use of VB-111 produced in @VBLTherapeutic Modi'in, Israel facility & company resumes US patient enrollment in Ph3 OVAL trial. https://t.co/E2pV410Asc $vblt #clinicaltrials #fda #cmc #oncology #OvarianCancer

[IM Therapeutics @IM_Therapeutics]

#ICYMI: @PharmaReview featured an article on how we’re building a broad pipeline of genetically targeted, oral therapies for HLA-associated autoimmune diseases using our IMT-HALT small molecule drug discovery & development platform. Read the article here: https://t.co/6cT5f6aRMn

[John Simboli @WsgJohn]

Enjoyed my #BioBoss podcast https://t.co/ZN71S6hW3i conversation with Nandan Padukone, CEO of IM Therapeutics. Hear Nandan's thoughts about #leadership in #biopharma and how IM Therapeutics is targeting the root cause of #autoimmunity with human leukocyte antigen #HLAs

[Buddy Guy @TheRealBuddyGuy]

Thank you to everyone who tuned in to @PBS @PBSAmerMasters last night for the premiere of 'Buddy Guy: The Blues Chase The Blues Away". If you missed it, you can watch the full episode online here. - Team BG

https://t.co/apaU9SmCT3

[Buddy Guy @TheRealBuddyGuy]

"Funny thing about the blues -- you play 'em 'cause you got 'em. But when you play 'em, you lose 'em."

‘Buddy Guy: The Blues Chase The Blues Away’ TONIGHT on @PBS @PBSAmerMasters. Check your local listings. https://t.co/aWdSpaPYJ3 - Team BG